RÉSUMÉ
Objective:To compare the effects of different glucocorticoids on the pulmonary infection in patients with rheumatoid arthritis (RA).Methods: From January 2013 to February 2017,128 cases of patients with RA in our hospital were selected as the research object,all the cases were divided into observation group and control group with 64 cases in each group accorded to the random draw envelope principle.The observation group was given intra-articular injection of corticosteroid therapy,the control group was given oral glucocorticoid therapy,two groups were treated for 8 weeks.Results:The total effective rate of the observation group and the control group was 96.9% and 84.4% respectively,and the total effective rate of the observation group was significantly higher than that of the control group(P<0.05).The joint pain and joint swelling index of the observation group and the control group after treatment were sig-nificantly lower than that before the treatment (P<0.05),and the joint pain and joint swelling index of the observation group after treatment were significantly lower than that of the control group (P<0.05).The incidence of pulmonary infection in the observation group and the control group during treatment were 1.6% and 7.8%,respectively.The incidence of pulmonary infection in the observation group was significantly lower than that in the control group (P<0.05).The CRP and RF in the observation group after treatment were (10.11±3.19)mg/L and (50.22±19.82)U/ml that were significantly lower than the control group of (17.49±5.32) mg/L and (59.14±20.59)U/ml (P<0.05),while the CRP and RF values of the two groups after treatment was obviously lower than that before treatment (P<0.05).Conclusion: Compare with oral administration,intra articular injection of glucocorticoid for RA can reduce the incidence of pulmonary infection,inhibit the expression of inflammatory factors and RF,and promote the alleviation of clinical symptoms,thereby enhance the therapeutic effect.
RÉSUMÉ
Objective To observe the clinical efficacy of acupuncture at cranial sutures plus rehabilitation training in treating post-stroke spastic palsy.Method Sixty patients with post-stroke spastic palsy were randomized into a treatment group and a control group, 30 cases each. The treatment group was intervened by acupuncture at cranial sutures plus rehabilitation training, while the control group was intervened by rehabilitation training alone. The Modified Ashworth Scale (MAS), Fugl-Meyer Assessment, and activities of daily living (ADL) in the Modified Barthel Index (MBI) were observed before and after the treatment for the two groups.Result After the intervention, there was a significant difference in MAS score between the two groups (P<0.05). The FMA and ADL scores were changed significantly after the treatment in both groups (P<0.05). The FMA and ADL scores in the treatment group were significantly different from those in the control group after the treatment (P<0.05).Conclusion Acupuncture at cranial sutures plus rehabilitation is an effective approach in treating post-stroke spastic palsy.
RÉSUMÉ
Objective:for the full implementation of the "national price of medical services specification (hereinafter referred to as the 2012 edition of "standard".Method:through the Excel table of survey data analysis and summary,experts and industry representatives to demonstrate.Results:2012 edition of" standard "in the laboratory diagnosis of a total of 1 104,the city of Tianjin City 646 docking;laboratory diagnosis fees 1465,after consulting the various medical institutions in Tianjin city and to test the use of 1 121 experts to discuss docking,natural selection 274,not 70 docking docking;646 TCM Paul 606.Conclusion:Tianjin laboratory diagnosis project and the 2012 edition of" standard "docking pricing to take full account of health care and patients bearing avoid leading ability,and the current project pricing method,the operation conditions of big data investigation preliminary.
RÉSUMÉ
To study the pharmacokinetics and tissue distribution characteristics of α-hederin sodium salt in rats. 100 mg•kg⁻¹ α-hederin sodium salt was given to the rats by intragastric administration, and LC-MS/MS method was used to determine its concentration at different time in plasma and tissues. Plasma and tissue samples were treated with methanol protein deposition method. Main pharmacokinetic parameters were as follows: tmax (0.97±1.23) h, Cmax (222.53±57.28) μg•L⁻¹, AUC0-t (1 262±788.9) h•μg•L⁻¹, T1/2 (17.94±9.50) h. α-hederin can be detected in heart, liver, spleen, lung, kidney, brain, muscle and adipose. The results showed that α-hederin sodium salt was absorbed fast and eliminated slowly in rats after oral administration. It was widely distributed in body tissues and livers kept the highest concentrations among various tissues at different time, so it can be speculated that α-hederin may have certain targeting property on livers.
RÉSUMÉ
Objective: To study the chemical constituents of Gastrodia elata. Methods: The compounds were separated and purified by column chromatography and their structures were established by spectroscopic methods. Results: Nine compounds were isolated from the 50% ethanol extract of G. elata, whose structures were determined as 1-furan-2-yl-2-(4-hydroxy-phenyl)-ethane-1, 2-dione (1), 2, 4-bis (4-hydroxybenzl)-phenol (2), 4-(methoxymethyl) phenyl-1-O-β-D-glucopyranoside (3), 1-furan-2-yl-2-(4-hydroxy-phenyl)- ethanone (4), parishin B (5), parishin C (6), {1-[4-(β-D-glucopyranosyl-(1→3)-β-D-glucopyranosyloxy) benzyl], 2-[4-(β-D-glucopyranosyloxy) benzyl]} citrate (7), bis (4-hydroxybenzyl) sulfide (8), and di-(p-hydroxybenzy1) disulfide (9). Conclusion: Compound 1 is a new compound, named gastrofurodione, and compound 9 is isolated from this genus for the first time.
RÉSUMÉ
Objective: To study the chemical constituents of Acanthopanax senticosus. Methods: The compounds were separated and purified by column chromatography and their structures were identified by spectroscopic methods. Results: Twelve compounds were isolated from the chloroform and n-butanol extract of A. senticosus, and their structures were determined as ciwujiatone (1), eleutheroside B1 (2), tachioside (3), alimoxide (4), erythro-1-(4-hydroxy-3-methoxy-phenyl)-2-{4-[(E)-3-hydroxy-1-propenyl] -2-methoxy-phenoxy}-1,3-propanediol (5), erythro-1,2-bis(4-hydroxy-3- methoxyphenyl)-1,3-propanediol (6), tortoside A (7), episyringaresinol 4′-O-β-D-glucopyranoside (8), (+)-lyoniresinol (9), benzyl-O-α-L-rhamno-pyranosyl (1→6)-β-D-glucopyranoside (10), 2,6-dimethoxy-4-(3-hydroxy-propen-1-yl) phenyl-4-O-α-L-rhamno-pyranosyl- (1→6)-β-D-glucopyranoside (11), and nicotinamide (12). Conclusion: Compounds 3-5 and 10-12 are isolated from A. senticosus for the first time.
RÉSUMÉ
<p><b>OBJECTIVE</b>To investigate the effects of Osthol on the proliferation and differentiation of osteoblasts of rats (rat calvarial osteoblasts, ROB) cultured in vitro.</p><p><b>METHODS</b>The neonatal SD rat skull was segregated, and enzyme digestion was used to obtain bone cells which were cultured in MEM containing 10% FBS. The medium was changed every three days, and serial subcultivation was performed when cells covered with 90% of the culture dish. The Osthol was added to 96-well plates with final concentration of 1 x 10(-4) mol/L, 1 x 10(-5) mol/L, 1 x l0(-6) mol/L and 1 x10(-7) mol/L, and MTT method was used to evaluate the proliferation. Differentiation analysis: the alkaline phosphatase (ALP) activity was determined at the 3rd, 6th, 9th, 12th and 15th days separately after osteogenic induction culture. The synthesis of type I collagen was observed using immunohistochemical method at the 8th day. The ALP stain was performed at the 12th day. The alizarin red staining was done and calcified nodules was counted at the 14th day.</p><p><b>RESULTS</b>The Osthol with final concentration of 1 x 10(-4) mo/L inhibit the proliferation of ROB. The Osthol with final concentration of 1 x 10(-5) mol/L had no obvious influence on the proliferation of ROB, but it significantly promoted the activity of ALP, enhanced the synthesis of collagen type I and increased the number of calcified nodules.</p><p><b>CONCLUSION</b>The Osthol with final concentration of 1 x 10(-5) mol/L can promote differentiation and maturation of ROB, which may be active ingredients of Chinese drugs for the osteoporosis prophylaxis.</p>
Sujet(s)
Animaux , Femelle , Mâle , Rats , Phosphatase alcaline , Métabolisme , Différenciation cellulaire , Prolifération cellulaire , Cellules cultivées , Coumarines , Pharmacologie , Ostéoblastes , Biologie cellulaire , Rat Sprague-DawleyRÉSUMÉ
<p><b>OBJECTIVE</b>To detect serve acute respiratory syndrome-associated coronavirus (SARS-CoV) and SARS-like-CoV in fruit bats captured in Guangzhou and its vicinity.</p><p><b>METHODS</b>Totally 927 bats of 9 species (Cynopterus sphinx, Rousettus leschenaulti, Miniopterus schreibersi, Hipposideros pratti, Rhinolophusasinicus, Scotophilusakuhlii, Hipposideros Pomona, Rhinolophus affinis, and Rhinolophus pusillus) captured in Guangzhou and its vicinity from September 2004 to November 2005 were available for this investigation, from which 3,043 samples (813 throat swasb, 524 sera, 853 lung tissues and 853 colorectal tissue specimens) were obtained. SARS-Cov and SARS-like-CoV were detected in these specimens using diagnostic kit for novel coronavirus N protein (ELISA), SARS-CoV Virus RNA detection kit, fluorescence PCR, Genchip, RT-PCR and cell isolation culture methods.</p><p><b>RESULTS AND CONCLUSION</b>No SARS-CoV and SARS-like-CoV were detected in the 3043 samples, indicating the current absence of SARS-CoV and SARS-like-CoV in the bats captured in Guangzhou and its vicinity.</p>
Sujet(s)
Animaux , Humains , Chine , Épidémiologie , Chiroptera , Virologie , Vecteurs de maladies , Test ELISA , Protéines nucléocapside , Métabolisme , ARN viral , Génétique , RT-PCR , Virus du SRAS , Génétique , Métabolisme , Syndrome respiratoire aigu sévère , Épidémiologie , VirologieRÉSUMÉ
<p><b>OBJECTIVE</b>To study the preventive effect of recombinant human interferon alpha-2b for nasal spray against SARS and other common respiratory viral infections by serum-epidemiological method.</p><p><b>METHODS</b>A randomized, placebo-controlled, double-blind field trial study in populations with 14,391 persons from SARS prevalent cities or provinces in China during May-Jun, 2003 and Dec-Apr, 2004. Interferon alpha-2b was given twice per day, once 9 x 10(5) IU by nasal spray for 5 days. Serum samples were taken at 15 days after last administration. Serological tests included SARS IgG antibody and IgM antibodies against influenza B, parainfluenza virus types 1-3, adenovirus type 3, 7 and respiratory syncytial virus by using commercial ELISA kits.</p><p><b>RESULTS</b>No statistically significant difference in serum SARS IgG antibody positive rate was found between the interferon and control groups among 2,757 serum samples. On the other hand, after using interferon, all four respiratory viruses (parainfluenza virus types 1-3 influenza B, adenovirus types 3, 7 and respiratory syncytial virus) in interferon group had lower IgM antibody positive rates than those in control group. Among them there were statistically significant differences between the interferon and control groups for parainfluenza virus, influenza B and adenovirus. The preventive efficacy of interferon against four respiratory viruses was different, from high to low, the rank was Flu B (66.76%), parainfluenza types 1-3 (66.75%), RSV (39.61%) and adenovirus (32.86%). The average preventive efficacy was 50.27%.</p><p><b>CONCLUSION</b>The recombinant human interferon alpha-2b for nasal spray could decrease the rates of common respiratory viruses infection in the selected population.</p>
Sujet(s)
Adulte , Humains , Jeune adulte , Administration par voie nasale , Anticorps antiviraux , Sang , Antiviraux , Utilisations thérapeutiques , Méthode en double aveugle , Immunoglobuline G , Sang , Immunoglobuline M , Sang , Interféron alpha , Utilisations thérapeutiques , Protéines recombinantes , Infections de l'appareil respiratoire , Sang , Virologie , Virus du SRAS , Allergie et immunologie , Syndrome respiratoire aigu sévère , Sang , Résultat thérapeutiqueRÉSUMÉ
<p><b>OBJECTIVE</b>To evaluate the safety of recombinant human interferon alpha-2b for nasal spray for the prevention of SARS and other upper respiratory viral infections.</p><p><b>METHODS</b>Field epidemiologic evaluation was conducted, the design was randomized and had a synchronously parallel control group. In the study, the drugs were given for five days and all subjects were followed up for ten days.</p><p><b>RESULTS</b>During the period of using interferon, body temperature of the experimental group was normal compared to the control group. Experimental group had more influenza-like symptoms than the control group (P < 0.05), such as headache (4.83%-7.09%), dizziness (7.17%-11.63%), lassitude (8.55%-15.06%), muscular soreness (4.43%-7.09%), pharynx dryness (12.10%-17.85%), angina (6.25%-8.72%), abdominal pain (2.30%-5.50%) and diarrhea (2.45%-5.66%). Most of side effects reached their peak with in the first 3 days. Except for pharynx dryness, the incidences of all other side effects declined after completion of the use of the trial drug, and incidences of some symptoms in experimental group were lower than those of the control group. There were no significant differences in the symptoms of cough and expectoration between the experimental group and the control group. The incidence of exanthem in the control group was significantly higher than that in the experimental group. The side effect of bloody nasal mucus was not observed in experimental group, which had been reported by other authors in several volunteer studies.</p><p><b>CONCLUSION</b>Using recombinant human interferon alpha-2b for nasal spray could lead to some influenza-like symptoms, however, all those symptoms were mild , reversible, and relieved after completion of the use of the trial drug. No serious side effects were found during the period of following up. The authors conclude that the drug is safe.</p>
Sujet(s)
Adolescent , Adulte , Femelle , Humains , Mâle , Jeune adulte , Douleur abdominale , Antiviraux , Utilisations thérapeutiques , Sensation vertigineuse , Études de suivi , Céphalée , Interféron alpha , Utilisations thérapeutiques , Protéines recombinantes , Virus du SRAS , Syndrome respiratoire aigu sévère , Virologie , Résultat thérapeutiqueRÉSUMÉ
Novel macrolides epothilones, produced by cellulolytic myxobacterium Sorangium cellulosum, have the activity to promote microtubule assembly, and are considered to be a potential successor to the famous antitumor drug taxol. The biosynthetic genes leading to the epothilones are clustered into a large operon. The multi-enzyme complex is a hetero-gene cluster of polyketide synthase (PKS) and non-ribosomal peptide synthetases (NRPS) and contains several functional modules, i.e. a loading module, one NRPS module, eight PKS modules, and a P450 epoxidase. The former ten modules biosynthesize desoxyepothilone (epothilones C and D), which is then epoxidized at C12 and C13 and converted into epothilones (epothilones A and B) by the P450 epoxidase. The NRPS module is responsible for the formation of the thiazole side chain from cysteine. The biosynthesis procedure of epothilones can be divided into 5 stages, i.e. formation of holo-ACP/PCP, chain initiation and thiazole ring formation, chain elongation, termination and epoxidation, and post-modification. The analysis of the gene cluster and the biosynthetic pathway reveals that novel epothilone analogs could not only be produced by chemical synthesis/modification, tranditional microbial technologies, but also can be genetically manipulated through combinatiorial biosynthesis approaches.
Sujet(s)
Protéines bactériennes , Génétique , Métabolisme , Épothilones , Chimie , Métabolisme , Structure moléculaire , Famille multigénique , Génétique , Physiologie , Myxococcales , Génétique , Métabolisme , Amino-acid ligases , Génétique , Métabolisme , Polyketide synthases , Génétique , MétabolismeRÉSUMÉ
Lipids of Thamnidium elegans,Mortierella ramanninace,Rhizopus arrhizus,Pythium irregulare and Rhodotorulla aurantiaca were extracted by Soxhlet extraction,supercritical-CO 2 fluid extraction,acid-heating extraction and organic solvent extraction,respectively.Four extraction methods were evaluated on sample treatment,minimum sample quantity,requirements of apparatus,ability of treating sample and content of lipid.The components of fatty acids were analysed by gas chromatography.Soxhlet extraction can acquired maximum lipid content,but it took the most time.Supercritical-CO 2 fluid extraction and acid-heating extraction has a same lipid content which was lower than that of Soxhlet extraction.Acid-heating extraction was the most handy,and its ability to treat sample in a hour was the most powerful.Organic solvent extraction was less efficient.Acid-heating extraction was a simple and efficient method of fungi lipid extraction fitting to breed mutant strains that highly producting lipid and polyunsaturated fatty acids.